教職人員
|
學歷：
國立臺灣大學臨床醫學研究所博士
國立臺灣大學醫學系學士
經歷：
國立臺灣大學醫學院附設醫院腫瘤醫學部主治醫師
國立台灣大學醫學系及臨床藥學研究所臨床副教授
美國國家癌症研究中心腫瘤內科次專科訓練醫師
美國國家癌症研究中心腫瘤內科交換學者
國立臺灣大學醫學院附設醫院內科住院醫師
榮譽：
．2003年國科會研究獎助
．2002年國科會研究獎助
．2002年中研院生醫所醫師研究獎助
．2001年國科會甲種研究獎助
．2000年國科會乙種研究獎助
．1999年國科會乙種研究獎助
．1999年台大醫院醫療服務獎
．1999年中華民國癌症醫學會最佳論文獎
．1998年中研院生醫所博士班醫師研究獎助
．1997年中研院生醫所博士班醫師研究獎助
．1996年國科會乙種研究獎助
國立臺灣大學臨床醫學研究所博士
國立臺灣大學醫學系學士
經歷：
國立臺灣大學醫學院附設醫院腫瘤醫學部主治醫師
國立台灣大學醫學系及臨床藥學研究所臨床副教授
美國國家癌症研究中心腫瘤內科次專科訓練醫師
美國國家癌症研究中心腫瘤內科交換學者
國立臺灣大學醫學院附設醫院內科住院醫師
榮譽：
．2003年國科會研究獎助
．2002年國科會研究獎助
．2002年中研院生醫所醫師研究獎助
．2001年國科會甲種研究獎助
．2000年國科會乙種研究獎助
．1999年國科會乙種研究獎助
．1999年台大醫院醫療服務獎
．1999年中華民國癌症醫學會最佳論文獎
．1998年中研院生醫所博士班醫師研究獎助
．1997年中研院生醫所博士班醫師研究獎助
．1996年國科會乙種研究獎助
A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
(2026-05) Lu, Shun ; Kato, Terufumi ; Dong, Xiaorong ; Ahn, Myung-Ju ; Quang, Le-Van ; Soparattanapaisarn, Nopadol ; Inoue, Takako ; Wang, Chih-Liang ; Huang, Meijuan ; CHIH-HSIN YANG ; Cobo, Manuel ; Özgüroğlu, Mustafa ; Casarini, Ignacio ; Sriuranpong, Virote ; Cronemberger, Eduardo ; Takahashi, Toshiaki ; Runglodvatana, Yotsawaj ; Chen, Ming ; Huang, Xiangning ; Grainger, Ellie ; Ghiorghiu, Dana ; van der Gronde, Toon ; Ramalingam, Suresh S
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report.
(2026-04-28) Hayashi, Hidetoshi ; Cho, Byoung Chul ; Spigel, David R ; Girard, Nicolas ; Lee, Se-Hoon ; Lu, Shun ; Popat, Sanjay ; CHIH-HSIN YANG ; Passaro, Antonio ; Baldotto, Clarissa ; Gottfried, Maya ; Dias, Josiane Mourão ; Zimmer Gelatti, Ana Caroline ; Wang, Bo ; Kam, Julian ; Sethi, Seema ; Shah, Sujay ; Kamat, Medha ; Zhang, Jiarui ; Curtin, Joshua C ; William, William N ; Besse, Benjamin
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis.
(2026-04) Hayashi, Hidetoshi ; Cho, Byoung Chul ; Kim, Yu Jung ; Lee, Se-Hoon ; Danchaivijitr, Pongwut ; Alip, Adlinda ; Xiong, Hailin ; How, Soon-Hin ; Chang, Gee-Chen ; CHIH-HSIN YANG ; Yamanaka, Yuta ; Nahit Şendur, Mehmet Ali ; Prabhash, Kumar ; Azuma, Koichi ; Akawung, Alianu ; Fennema, Elizabeth ; Tang, Xiaodan ; Shah, Sujay ; Sethi, Seema ; Lu, Shun
Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group.
(2026-03-26) Tan, Aaron C ; Liao, Bin-Chi ; Li, Molly ; Lee, David ; Uehara, Yuji ; Thamlikitkul, Lucksamon ; Zhang, Jia-Tao ; Zheng, Meimei ; Lee, Chee Khoon ; Pavlakis, Nick ; John, Thomas ; Soo, Ross A ; Skanderup, Anders ; Voon, Pei Jye ; Ahn, Beung-Chul ; Park, Sehhoon ; Hayashi, Hidetoshi ; Goto, Yasushi ; Horinouchi, Hidehito ; Yatabe, Yasushi ; Reungwetwattana, Thanyanan ; CHIH-HSIN YANG ; Kim, Dong-Wan ; Mok, Tony ; Tan, Daniel S W ; Wu, Yi-Long ; Ahn, Myung-Ju
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.
(2026-03) Woodford, Rachel ; Lord, Sally ; John, Tom ; CHIH-HSIN YANG ; Simes, John ; Marschner, Ian ; Lee, Chee Khoon
(2026-05) Lu, Shun ; Kato, Terufumi ; Dong, Xiaorong ; Ahn, Myung-Ju ; Quang, Le-Van ; Soparattanapaisarn, Nopadol ; Inoue, Takako ; Wang, Chih-Liang ; Huang, Meijuan ; CHIH-HSIN YANG ; Cobo, Manuel ; Özgüroğlu, Mustafa ; Casarini, Ignacio ; Sriuranpong, Virote ; Cronemberger, Eduardo ; Takahashi, Toshiaki ; Runglodvatana, Yotsawaj ; Chen, Ming ; Huang, Xiangning ; Grainger, Ellie ; Ghiorghiu, Dana ; van der Gronde, Toon ; Ramalingam, Suresh S
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report.
(2026-04-28) Hayashi, Hidetoshi ; Cho, Byoung Chul ; Spigel, David R ; Girard, Nicolas ; Lee, Se-Hoon ; Lu, Shun ; Popat, Sanjay ; CHIH-HSIN YANG ; Passaro, Antonio ; Baldotto, Clarissa ; Gottfried, Maya ; Dias, Josiane Mourão ; Zimmer Gelatti, Ana Caroline ; Wang, Bo ; Kam, Julian ; Sethi, Seema ; Shah, Sujay ; Kamat, Medha ; Zhang, Jiarui ; Curtin, Joshua C ; William, William N ; Besse, Benjamin
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis.
(2026-04) Hayashi, Hidetoshi ; Cho, Byoung Chul ; Kim, Yu Jung ; Lee, Se-Hoon ; Danchaivijitr, Pongwut ; Alip, Adlinda ; Xiong, Hailin ; How, Soon-Hin ; Chang, Gee-Chen ; CHIH-HSIN YANG ; Yamanaka, Yuta ; Nahit Şendur, Mehmet Ali ; Prabhash, Kumar ; Azuma, Koichi ; Akawung, Alianu ; Fennema, Elizabeth ; Tang, Xiaodan ; Shah, Sujay ; Sethi, Seema ; Lu, Shun
Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group.
(2026-03-26) Tan, Aaron C ; Liao, Bin-Chi ; Li, Molly ; Lee, David ; Uehara, Yuji ; Thamlikitkul, Lucksamon ; Zhang, Jia-Tao ; Zheng, Meimei ; Lee, Chee Khoon ; Pavlakis, Nick ; John, Thomas ; Soo, Ross A ; Skanderup, Anders ; Voon, Pei Jye ; Ahn, Beung-Chul ; Park, Sehhoon ; Hayashi, Hidetoshi ; Goto, Yasushi ; Horinouchi, Hidehito ; Yatabe, Yasushi ; Reungwetwattana, Thanyanan ; CHIH-HSIN YANG ; Kim, Dong-Wan ; Mok, Tony ; Tan, Daniel S W ; Wu, Yi-Long ; Ahn, Myung-Ju
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.
(2026-03) Woodford, Rachel ; Lord, Sally ; John, Tom ; CHIH-HSIN YANG ; Simes, John ; Marschner, Ian ; Lee, Chee Khoon
腫瘤免疫微環境特性及表皮生長因子受體突變非小細胞肺癌免疫抑制機制探索( I )=Characterization of Tumor Immune Microenvironment and Exploration of Immunosuppression Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer( I )
(2024-08-01～) CHIH-HSIN YANG
Expanding Caregiving Capacities for Caregivers of Older Adults with Newly Diagnosed Advanced Lung Cancer: a Study of Current Status and Evaluation of the "Integrating Nurse-Led and Resource Utilization-Based Caregiver Support Model (Icsm)" = 擴展新診斷晚期肺癌老年病人主要照顧者之照護能力及資源運用: 現況探討與測試"整合護理引導及資源使用之照護者支持模式"
(2024-08-01～) YEUR-HUR LAI
國立臺灣大學高等教育深耕計畫－特色領域研究中心 【子計畫三_癌症】
(2023-01-02～) CHIH-HSIN YANG
Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer Cells
(2022-08-01～) CHIH-HSIN YANG
Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer Cells
(2021-08-01～) CHIH-HSIN YANG
(2024-08-01～) CHIH-HSIN YANG
Expanding Caregiving Capacities for Caregivers of Older Adults with Newly Diagnosed Advanced Lung Cancer: a Study of Current Status and Evaluation of the "Integrating Nurse-Led and Resource Utilization-Based Caregiver Support Model (Icsm)" = 擴展新診斷晚期肺癌老年病人主要照顧者之照護能力及資源運用: 現況探討與測試"整合護理引導及資源使用之照護者支持模式"
(2024-08-01～) YEUR-HUR LAI
國立臺灣大學高等教育深耕計畫－特色領域研究中心 【子計畫三_癌症】
(2023-01-02～) CHIH-HSIN YANG
Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer Cells
(2022-08-01～) CHIH-HSIN YANG
Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer Cells
(2021-08-01～) CHIH-HSIN YANG